¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"complications of ventriculo-peritoneal shunt"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® shunt ÇÑ±Û Áö¸§±æ, Áö¸§¼ú, ´Ü¶ô
¼³¸í   
  1. ÇÑÂÊÀ¸·Î µ¹¾Æ°¡´Ù, ÀüȯÇÏ´Ù, ¿ìȸÇÏ´Ù. 2. Ç÷°ü°£ÀÇ Åë·Î ¶Ç´Â ¿¬°á.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • ventriculoperitoneal shunt
    ³ú½Çº¹°­¼ÇÆ®
  • ventriculoperitoneal
    ³ú½Çº¹°­-, ³ú½Ç¹è¾È-
  • arteriovenous shunt
    µ¿Á¤¸Æ¼ÇÆ®
  • bypass shunt
    ¿ìȸ¼ÇÆ®
  • cardiovascular shunt
    ½ÉÀåÇ÷°ü¼ÇÆ®
  • intracardiac shunt
    ½ÉÀå³»¼ÇÆ®
  • left-to-right shunt
    Á¿ì¼ÇÆ®
  • lumboperitoneal shunt
    ¿äÃߺ¹°­¼ÇÆ®
  • mesocaval shunt
    ´ëÁ¤¸Æ°£¸·¼ÇÆ®
  • mesocaval shunt operation
    ´ëÁ¤¸Æ°£¸·¼ÇÆ®¼ö¼ú
  • portacaval shunt
    ¹®¸Æ´ëÁ¤¸Æ¼ÇÆ®
  • portocaval shunt operation
    ¹®¸Æ´ëÁ¤¸Æ¼ÇÆ®¼ö¼ú
  • portosystemic shunt
    ¹®¸ÆÀü½Å¼ÇÆ®
  • peritoneovenous shunt
    º¹°­Á¤¸Æ¼ÇÆ®
  • right to left shunt
    ¿À¸¥¿ÞÂÊ¼ÇÆ®, ¿ìÁÂ¼ÇÆ®
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • ventriculoperitoneal shunt
    ³ú½Çº¹°­Áö¸§¼ú
  • shunt circuit
    Áö¸§±æ
  • portocaval shunt operation
    ¹®¸Æ´ëÁ¤¸ÆÁö¸§¼ú, ¹®¸Æ´ëÁ¤¸Æ¿¬°á¼ú
  • shunt operation
    Áö¸§¼ú, ´Ü¶ô¼ú, ¼ÇÆ®¼ö¼ú
  • shunt
    Áö¸§±æ, Áö¸§¼ú, ¼ÇÆ®, »çÀÕ±æ
  • lumboperitoneal shunt
    ¿äÃߺ¹°­Áö¸§¼ú
  • peritoneovenous shunt
    º¹°­Á¤¸ÆÁö¸§¼ú, ¹è¸·Á¤¸ÆÁö¸§¼ú
  • right to left shunt
    ¿À¸¥¿ÞÁö¸§±æ
  • transjugular intrahepatic portosystemic shunt
    ¸ñÁ¤¸Æ°æÀ¯°£¼Ó¹®¸ÆÀü½Å¼øÈ¯Áö¸§¼ú, ¸ñÁ¤¸Æ°æÀ¯°£¼Ó¹®¸ÆÀü½Å¼øÈ¯¿¬°á¼ú
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • ventriculoperitoneal
    ³ú½Çº¹°­-, ³ú½Ç¹è¾È-
  • arteriovenous shunt
    µ¿Á¤¸ÆÁö¸§±æ, µ¿Á¤¸ÆÁö¸§¼ú
  • bypass shunt
    ¿ìȸ·ÎÁö¸§±æ, ¿ìȸ·ÎÁö¸§¼ú
  • cardiaovascular shunt
    ½ÉÀåÇ÷°üÁö¸§±æ
  • shunt circuit
    Áö¸§±æ
  • shunt effect
    Áö¸§±æÈ¿°ú, ¼ÇƮȿ°ú
  • intracardiac shunt
    ½ÉÀå³»Áö¸§±æ
  • mesocaval shunt operation
    âÀÚ°£¸·´ëÁ¤¸Æ¿¬°á¼ú, Àå°£¸·Á¤¸Æ´ëÁ¤¸Æ¿¬°á¼ú
  • shunt malfunction
    Áö¸§±æ±â´ÉÀå¾Ö
  • shunt operation
    Áö¸§¼ú, ´Ü¶ô¼ö¼ú
  • paracellular shunt
    ¼¼Æ÷ÁÖÀ§Áö¸§±æ
  • portacaval shunt
    ¹®¸Æ´ëÁ¤¸ÆÁö¸§(¼ú), ¹®¸Æ´ëÁ¤¸Æ¿¬°á(¼ú)
  • portosystemic shunt
    ¹®¸ÆÀü½Å¼øÈ¯Áö¸§¼ú, ¹®¸ÆÀü½Å¼øÈ¯¿¬°á¼ú
  • renal shunt
    ÄáÆÏÇ÷·ùÁö¸§±æ, ½ÅÀåÇ÷·ùÁö¸§±æ
  • shunt
    Áö¸§±æ, Áö¸§¼ú, ´Ü¶ô
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • postoperative complications
    ¼úÈÄÇÕº´Áõ(¡­ÇÕº´Áõ).
  • postoperative complications
    ¼úÈÄÇÕº´Áõ(âúý­ùêܱñø)
  • Hexose monophosphate shunt
    À°Åº´çÀÏÀλ꿰ȸ·Î
  • Torkildsons shunt
    Åäųµå½¼´Ü¶ô.
  • arteriovenous shunt
    µ¿Á¤¸Æ¼ÇÆ®, µ¿Á¤¸Æ´Ü¶ô(¡­Ó­Õ©)
  • arteriovenous shunt
    µ¿Á¤¸Æ¼ÇÆ®, µ¿Á¤¸Æ´Ü¶ô(¡­´Ü¶ô).
  • hexose monophosphate shunt
    ÀÏÀλêÇí¼Ò½º¼ÇÆ®<--´Ü¶ô>
  • portacaval shunt
    ¹®¸Æ´ëÁ¤¸Æ¹®ÇÕ(¼ú)(¹®¸Æ´ëÁ¤¸Æ¹®ÇÕ¼ú).
  • porto-systemic shunt
    ¹®¸ÆÃ¼´Ü¶ô(Ó­Õ©)<--¼ÇÆ®>
  • portosystemic shunt
    ¹®¸ÆÀü½Å¼øÈ¯¹®ÇÕ¼ú(Ú¦Øæîïãóâàü»Ùüùêâú), ¹®¸ÆÀü½Å¼øÈ¯¼ÇÆ®((Ú¦Øæîïãóâàü»¡­)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • ventriculoperitoneal
    ³ú½Çº¹(¸·)°­(ÒàãøÜ٠د˷).
  • myocardial infarction,complications of
    ÇÕº´Áõ(ùêܱñø)
  • postoperative complications
    ¼úÈÄÇÕº´Áõ(¡­ÇÕº´Áõ).
  • postoperative complications
    ¼úÈÄÇÕº´Áõ(âúý­ùêܱñø)
  • arteriovenous shunt
    µ¿Á¤¸Æ¼ÇÆ®, µ¿Á¤¸Æ´Ü¶ô(¡­Ó­Õ©)
  • arteriovenous shunt
    µ¿Á¤¸Æ¼ÇÆ®, µ¿Á¤¸Æ´Ü¶ô(¡­´Ü¶ô).
  • bypass shunt
    ¿ìȸ·Î ´Ü¶ô(éæüÞÖØÓ­Õ©).
  • bypass shunt
    ȸ·Î°£µµ, ȸ·Î´Ü¶ô(ȸ·Î´Ü¶ô), ¿ìȸ·Î´Ü¶ô.
  • bypass shunt
    ¼øÈ­ [½Å¿Ü,ÈäºÎ]ȸ ·Î°£µµ, ȸ·Î´Ü¶ô(üßÖØÓ­Õ©), ¿ìȸ·Î´Ü¶ô.
  • cardiac shunt
    ½É´Ü¶ô(ãýÓ­Õ©)
  • hexose monophosphate shunt
    ÀÏÀλêÇí¼Ò½º¼ÇÆ®<--´Ü¶ô>
  • intracardiac shunt
    ½ÉÀå³»´Ü¶ô(¡­Ó­Õ©).
  • juxtamedullary shunt
    (¼öÁú)±ÙÁ¢ºÎ´Ü¶ô(âÐòõÐÎïÈݻӭթ).
  • left-to-right shunt
    Á¿ì¼ÇÆ®(ñ§éÓ¡­)
  • mesocaval shunt operation
    Àå°£¸·Á¤¸Æ´ëÁ¤¸Æ¹®ÇÕ¼ú(Àå°£¸·Á¤¸Æ´ëÁ¤¸Æ¹®ÇÕ¼ú).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • GABA shunt
    GABA ºÐ·Î(ÝÂÖØ)
  • hoxose monophosphate shunt
    ÀÏÀλê(ìé×òß«) Çí¼Ò½º ºÐ·Î(ÝÂÖØ)
  • HMP shunt
    HMP ºÐ·Î(ÝÂÖØ)
  • metabolic shunt
    ´ë»ç ºÐ·Î(ÓÛÞóÝÂÖØ)
  • shunt
    ºÐ·Î(ÝÂÖØ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • postoperative complications
    ¼úÈÄÇÕº´Áõ
  • ventriculoperitoneal
    ³ú½Çº¹(¸·)°­
  • arterioportal shunt
    µ¿¸Æ¹®¸Æ´Ü¶ô
  • intracardiac shunt
    ½ÉÀå³»´Ü¶ô
  • shunt
    ¼ÇÆ®, ´Ü¶ô
  • splenorenal shunt
    ºñ½ÅÁ¤¸ÆÀü·ù¼ú
  • TIPS [=transjugular intrahepatic portosystemic shunt]
    °æ°æÁ¤¸Æ°£³»¹®¸ÆÁ¤¸Æ´Ü¶ô¼ú
  • transjugular intrahepatic portosystemic shunt [=TIPS]
    °æ°æÁ¤¸Æ°£³»¹®¸ÆÁ¤¸Æ´Ü¶ô¼ú
  • ventriculocaval shunt
    ³ú½Ç»ó´ëÁ¤¸Æ´Ü¶ô(¼ú)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
VPS ventriculoperitoneal shunt; verbal pain scale; virtual point source; visual pleural space; volume pe...
HIVD Herniation(Herniated) of Inter-Vertebral Disc
  - Cervical HIVD
   &...
B-T shunt Blalock-Taussig shunt
HMP Shunt Hexose Mono-Phosphate Shunt
LP shunt Lumbo-Peritoneal shunt
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
EDC Epidemiology of Diabetes Complications
PPC Postoperative pulmonary complications
EPIC the Prevention of Ischaemic Complications
DSRS Distal splenorenal shunt
HMPS Hexose monophosphate shunt
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • anteriovenous shunt appliance
    µ¿Á¤¸Æ Ãø·ÎÀåÄ¡
  • arteriovenous shunt
    µ¿Á¤¸Æ ´Ü¶ô
  • hexose monophosphate shunt
    ÀÏÀλê Çí¼Ò½º ¼ÇÆ®
  • intracardiac shunt
    ½ÉÀå ³» ´Ü¶ô
  • juxtamedullary shunt
    ¼öÁú ±ÙÁ¢ºÎ ´Ü¶ô
  • shunt cyanosis
    ºÐÇÕ¼º û»öÁõ
    »ê¼Ò ºÒÆ÷È­ Ç÷¾×ÀÌ ½ÉÀå ¶Ç´Â ´ëÇ÷°üÀÇ µ¿¸Æ Ç÷¾×¿¡ È¥ÇÕµÊÀ¸·Î½á ¹ß»ýÇϴ û»öÁõ.
  • shunt-in personality
    ÀÚÆó¼º ÀΰÝ
  • splenorenal shunt
    ºñ½ÅÁ¤¸Æ Àü·ù¼ú
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
complications of ventriculo-peritoneal shunt <radiology> Kinking, interruption, exit from peritoneal cavity with growth, through processus vaginalis to scrotum, CSFoma, mass effect exhibited on bowel gas pattern with malfunctioning shunt, lack of movement of shunt tip with positional or temporal change, perforation of hollow viscus (e.g., bowel or bladder)
(12 Dec 1998)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
ventriculoperitoneal shunt <procedure> A surgical procedure to insert a communicating catheter to relieve intracranial pressure caused by hydrocephalus.
In this procedure the cerebrospinal fluid is shunted from the ventricles of the brain into the peritoneal cavity via a surgically implanted tube.
(27 Sep 1997)
postoperative complications Disorders affecting patients after surgery. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery.
(12 Dec 1998)
pregnancy complications The co-occurrence of pregnancy and a disease. The disease may precede or follow conception and it may or may not have a deleterious effect on the pregnant woman or foetus.
(12 Dec 1998)
pregnancy complications, cardiovascular The co-occurrence of pregnancy and a cardiovascular disease. The disease may precede or follow conception and it may or may not have a deleterious effect on the pregnant woman or foetus.
(12 Dec 1998)
pregnancy complications, haematologic The co-occurrence of pregnancy and a blood disease. The haematologic disorder may be of the cells or coagulation elements of the blood but does not refer to deficiencies or excesses of various substances in the blood, such as hypercalcaemia or hypocalcaemia. It may precede or follow conception and it may or may not have a deleterious effect on the pregnant woman or foetus.
(12 Dec 1998)
pregnancy complications, infectious Infections occurring during the course of pregnancy, or pregnancy during the course of an infectious disease.
(12 Dec 1998)
pregnancy complications, neoplastic Neoplasms occurring during the course of pregnancy, or pregnancy during the course of a neoplastic disease.
(12 Dec 1998)
pregnancy complications, parasitic Parasitic diseases occurring during the course of pregnancy, or pregnancy during the course of a parasitic disease. Some of the more commonly co-occurring infections are amebiasis, malaria and toxoplasmosis.
(12 Dec 1998)
intraoperative complications Disorders affecting patients during surgery. They may or may not be related to the disease for which the surgery is done. They may or may not be direct results of the surgery.
(12 Dec 1998)
labour complications <obstetrics> Medical problems associated with labour including cephalopelvic disproportion, haemorrhage, foetal distress, or other disorders.
(12 Dec 1998)
arteriovenous shunt <anatomy, surgery> A direct connection between an artery and vein. Most often due to the surgical joining of an artery and a vein under the skin for the purpose of haemodialysis.
Larger arteriovenous shunts can create significant extra workload on the heart since arterial blood is diverted back to the venous circulation before it has a chance to deliver nutrients and oxygen to the body tissues.
(20 Jun 2000)
A-V shunt <anatomy, surgery> A direct connection between an artery and vein. Most often due to the surgical joining of an artery and a vein under the skin for the purpose of haemodialysis.
Larger arteriovenous shunts can create significant extra workload on the heart since arterial blood is diverted back to the venous circulation before it has a chance to deliver nutrients and oxygen to the body tissues.
(20 Jun 2000)
Blalock shunt Subclavian artery to pulmonary artery shunt to increase pulmonary circulation in cyanotic heart disease with decreased pulmonary flow.
(05 Mar 2000)
Blalock-Taussig shunt A palliative subclavian artery to pulmonary artery anastomosis.
(05 Mar 2000)
Rapoport-Luebering shunt Part of the glycolytic pathway characteristic of human erythrocytes in which 2,3-bisphosphoglycerate (2,3-P2Gri) is formed as an intermediate between 1,3-P2Gri and 3-phosphoglycerate; 2,3-P2Gri is an important regulator of the affinity of haemoglobin for oxygen.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • shunt
    À» ´Ý´Ù
  • shunt
    ¿·À¸·Î µ¹¸®´Ù;Á¦°ÅÇÏ´Ù;ÇÑÂÊÀ¸·Î ºñŰ´Ù;Ãø¼±¿¡ ³Ö´Ù;Àüö(ÀÔÇÑ)ÇÏ´Ù;ÇÑÂÊÀ¸·Î ºñŰ´Ù;Ãø¼±À¸·Î µé¾î°¡´Ù;Àüö(±â)ºÐ·Î
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á